Comment on

• Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

  EVOLVE Trial Investigators; Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. EVOLVE Trial Investigators, et al. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121374 Clinical Trial.
• Cinacalcet for cardiovascular disease in patients undergoing dialysis.

  Urena-Torres P, Prié D, Souberbielle JC. Urena-Torres P, et al. N Engl J Med. 2013 May 9;368(19):1842-3. doi: 10.1056/NEJMc1301247. N Engl J Med. 2013. PMID: 23656654 No abstract available.
• Cinacalcet for cardiovascular disease in patients undergoing dialysis.

  Locatelli F, Pontoriero G, Tentori F. Locatelli F, et al. N Engl J Med. 2013 May 9;368(19):1843. doi: 10.1056/NEJMc1301247. N Engl J Med. 2013. PMID: 23656655 No abstract available.
• Cinacalcet for cardiovascular disease in patients undergoing dialysis.

  Goldsmith DJ, Lamb EJ. Goldsmith DJ, et al. N Engl J Med. 2013 May 9;368(19):1843. doi: 10.1056/NEJMc1301247. N Engl J Med. 2013. PMID: 23656656 No abstract available.
• Cinacalcet for cardiovascular disease in patients undergoing dialysis.

  Tripepi G. Tripepi G. N Engl J Med. 2013 May 9;368(19):1843-4. doi: 10.1056/NEJMc1301247. N Engl J Med. 2013. PMID: 23656657 No abstract available.